Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $10.77 down -4.73% from its previous closing price of $11.31. In other words, the price has decreased by -$4.73 from its previous closing price. On the day, 1.36 million shares were traded. NMRA stock price reached its highest trading level at $11.73 during the session, while it also had its lowest trading level at $10.755.
Ratios:
For a deeper understanding of Neumora Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.98 and its Current Ratio is at 10.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on November 05, 2024, Downgraded its rating to Neutral and sets its target price to $15 from $18 previously.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
On July 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $23.Needham initiated its Buy rating on July 22, 2024, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 18 ’24 when Fust Matthew K sold 14,049 shares for $17.03 per share. The transaction valued at 239,319 led to the insider holds 20,100 shares of the business.
Fust Matthew K sold 7,739 shares of NMRA for $131,643 on Oct 17 ’24. The Director now owns 20,100 shares after completing the transaction at $17.01 per share. On Oct 18 ’24, another insider, Fust Matthew K, who serves as the Director of the company, bought 14,049 shares for $17.03 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 1809079296 and an Enterprise Value of 1441881856.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $8.33. The 50-Day Moving Average of the stock is -17.58%, while the 200-Day Moving Average is calculated to be -14.23%.
Shares Statistics:
For the past three months, NMRA has traded an average of 955.42K shares per day and 1128210 over the past ten days. A total of 158.83M shares are outstanding, with a floating share count of 54.91M. Insiders hold about 65.69% of the company’s shares, while institutions hold 28.72% stake in the company. Shares short for NMRA as of 1728950400 were 9008776 with a Short Ratio of 9.80, compared to 1726185600 on 9523723. Therefore, it implies a Short% of Shares Outstanding of 9008776 and a Short% of Float of 10.74.
